Crossmark Global Holdings’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,570
| Closed | -$631K | – | 1285 |
|
|
2022
Q3 | $631K | Sell |
2,570
-150
| -6% | -$36.8K | 0.02% | 683 |
|
|
2022
Q2 | $673K | Hold |
2,720
| – | – | 0.02% | 691 |
|
|
2022
Q1 | $901K | Buy |
2,720
+50
| +2% | +$16.6K | 0.02% | 665 |
|
|
2021
Q4 | $959K | Sell |
2,670
-4,680
| -64% | -$1.68M | 0.02% | 641 |
|
|
2021
Q3 | $2.39M | Sell |
7,350
-550
| -7% | -$179K | 0.06% | 340 |
|
|
2021
Q2 | $2.47M | Sell |
7,900
-520
| -6% | -$162K | 0.06% | 324 |
|
|
2021
Q1 | $2.68M | Sell |
8,420
-1,140
| -12% | -$363K | 0.07% | 298 |
|
|
2020
Q4 | $3.1M | Buy |
9,560
+6,670
| +231% | +$2.16M | 0.08% | 280 |
|
|
2020
Q3 | $801K | Sell |
2,890
-130
| -4% | -$36K | 0.02% | 606 |
|
|
2020
Q2 | $730K | Sell |
3,020
-20
| -0.7% | -$4.83K | 0.02% | 633 |
|
|
2020
Q1 | $441K | Sell |
3,040
-104
| -3% | -$15.1K | 0.02% | 695 |
|
|
2019
Q4 | $536K | Sell |
3,144
-147
| -4% | -$25.1K | 0.01% | 768 |
|
|
2019
Q3 | $585K | Buy |
3,291
+49
| +2% | +$8.71K | 0.02% | 725 |
|
|
2019
Q2 | $845K | Buy |
3,242
+104
| +3% | +$27.1K | 0.02% | 596 |
|
|
2019
Q1 | $896K | Sell |
3,138
-109
| -3% | -$31.1K | 0.03% | 580 |
|
|
2018
Q4 | $1.06M | Sell |
3,247
-3,795
| -54% | -$1.23M | 0.03% | 517 |
|
|
2018
Q3 | $3.17M | Buy |
7,042
+92
| +1% | +$41.4K | 0.08% | 282 |
|
|
2018
Q2 | $2.84M | Buy |
6,950
+733
| +12% | +$300K | 0.08% | 290 |
|
|
2018
Q1 | $1.81M | Sell |
6,217
-310
| -5% | -$90.2K | 0.05% | 440 |
|
|
2017
Q4 | $1.22M | Sell |
6,527
-563
| -8% | -$105K | 0.03% | 575 |
|
|
2017
Q3 | $1.2M | Buy |
+7,090
| New | +$1.2M | 0.03% | 558 |
|
|
2016
Q3 | $1.2M | Buy |
+7,090
| New | +$1.2M | 0.03% | 558 |
|